The estimated Net Worth of Steven George Hughes is at least $1.4 Million dollars as of 16 August 2019. Steven Hughes owns over 22,230 units of Organovo Inc stock worth over $76,111 and over the last 6 years he sold ONVO stock worth over $6,447. In addition, he makes $1,313,490 as Chief Medical Officer at Organovo Inc.
Steven has made over 1 trades of the Organovo Inc stock since 2019, according to the Form 4 filled with the SEC. Most recently he sold 22,230 units of ONVO stock worth $6,447 on 16 August 2019.
The largest trade he's ever made was selling 22,230 units of Organovo Inc stock on 16 August 2019 worth over $6,447. On average, Steven trades about 5,558 units every 0 days since 2018. As of 16 August 2019 he still owns at least 138,484 units of Organovo Inc stock.
You can see the complete history of Steven Hughes stock trades at the bottom of the page.
Dr. Steven Hughes serves as Chief Medical Officer of the Company. He has more than 20 years of experience building and leading clinical development and medical affairs teams at leading biopharma companies. He has been involved in more than 50 clinical trials with more than 25 drugs across multiple therapeutic areas including cardiovascular, metabolic, neurology, oncology, infectious diseases, rheumatology, ophthalmology and rare diseases, in the U.S. and other regions. Dr. Hughes has also played a key role in the submission of multiple NDA/MAA applications. He most recently served as the Chief Clinical Development Officer at Ionis Pharmaceuticals, where he led a team that managed the global clinical development of multiple drugs across 10 therapeutic areas. Previously, he held positions as Global Medical Lead, Oncology Clinical Development and Medical Director, UK & Ireland at Biogen Idec. Dr. Hughes also held numerous senior clinical development, medical affairs and leadership positions of increasing responsibility at CSL Behring and Sanofi. Dr. Hughes is board certified in Pharmaceutical Medicine and received his medical degree from Imperial College, London. He also has an MBA with distinction from Imperial College Business School.
As the Chief Medical Officer of Organovo Inc, the total compensation of Steven Hughes at Organovo Inc is $1,313,490. There are no executives at Organovo Inc getting paid more.
Steven Hughes is 53, he's been the Chief Medical Officer of Organovo Inc since 2018. There are 1 older and 2 younger executives at Organovo Inc. The oldest executive at Organovo Holdings Inc is Adam Stern, 56, who is the Independent Director.
Steven's mailing address filed with the SEC is C/O ARCTURUS THERAPEUTICS HOLDINGS INC., 10628 SCIENCE CENTER DRIVE, SUITE 250, SAN DIEGO, CA, 92121.
Over the last 13 years, insiders at Organovo Inc have traded over $8,085,375 worth of Organovo Inc stock and bought 386,250 units worth $661,443 . The most active insiders traders include Mark Kessel, Keith Murphy, and Adam K Stern. On average, Organovo Inc executives and independent directors trade stock every 112 days with the average trade being worth of $29,354. The most recent stock trade was executed by David Gobel on 15 November 2023, trading 19,607 units of ONVO stock currently worth $31,763.
organovo (nyse mkt: onvo) designs and creates functional, three-dimensional human tissues for medical research and therapeutic applications. the company is collaborating with pharmaceutical and academic partners to develop human biological disease models in three dimensions. these 3d human tissues have the potential to accelerate the drug discovery process, enabling treatments to be developed faster and at lower cost. in addition to numerous scientific publications, their technology has been featured in the wall street journal, time magazine, the economist, and other outlets. organovo is changing the shape of medical research and practice.
Organovo Inc executives and other stock owners filed with the SEC include: